Praz­er Ther­a­peu­tics rais­es $20M; Caris­ma lets go of most staff

Plus, news about Cere­vance, On­copep­tides, LifeM­ine, Bavar­i­an Nordic and Ea­gle Phar­ma­ceu­ti­cals:

South Ko­re­an biotech’s Se­ries B: Praz­er Ther­a­peu­tics nabbed a $20 mil­lion Se­ries B from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER